HROW:NASDAQ
Harrow Inc
US$ ३०.६२
arrow_upward
+०.८९%(+०.२७) 1D
US$ ३०.५५
arrow_downward
-०.२३% (-०.०७०)todayPre-market
Closed: अक्टोबर ७, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HROW...
Open
US$ ३०.०९
High
US$ ३१.११
Low
US$ २९.९०
Mkt. cap
१.१५ अरब
Avg. vol.
५.४२ लाख
Volume
८५४.००
52-wk high
US$ ५४.८५
52-wk low
US$ २८.५४
EPS
-US$ १.००
Beta
०.१९
Shares outstanding
३.७५ करोड
No. of employees
३७३
Open
US$ ३०.०९
High
US$ ३१.११
Low
US$ २९.९०
Mkt. cap
१.१५ अरब
Avg. vol.
५.४२ लाख
Volume
८५४.००
52-wk high
US$ ५४.८५
52-wk low
US$ २८.५४
EPS
-US$ १.००
Beta
०.१९
Shares outstanding
३.७५ करोड
No. of employees
३७३
News stories
From web sources and news partners
Yahoo Finance Singapore
·
११ घण्टा पहिले
Is Harrow (HROW) Undervalued On Growing Conference Buzz Around Its Ophthalmic Pipeline?
Simply Wall Street
·
११ घण्टा पहिले
Is Harrow (HROW) Cheap After New Eye Drug Data Took Center Stage?
The Business Journals
·
२ दिन पहिले
Harrow invests $30 million in new pharmaceutical as it builds portfolio
TipRanks
·
३ दिन पहिले
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio
Profile
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
About Harrow Inc
CEOMark L. Baum Esq.
Employees३७३
Founded२०१२
Headquartersनेशविल, टेनेसी, संयुक्त राज्य अमेरिका
Sector-
Websiteharrow.com